Jacques‐Olivier Bay

Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial

Sylvie Négrier, Gwénaëlle Gravis, David Pérol et al. · The Lancet Oncology · 2011 · 236 citations

Urology, Genitourinary Cancer, Medicine +5

Management and outcome of primary CNS lymphoma in the modern era

Caroline Houillier, Carole Soussain, Hervé Ghesquières et al. · Neurology · 2020 · 229 citations · Full text

Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies

Gandhi Damaj, Alain Duhamel, Marie Robin et al. · Journal of Clinical Oncology · 2012 · 204 citations · Full text

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

Maud Toulmonde, Sylvie Bonvalot, Pierre Méeus et al. · Annals of Oncology · 2014 · 202 citations · Full text

Surgical Oncology, Multicenter Analysis, Surgical Pathology +4

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

Mohamad Mohty, Jacques‐Olivier Bay, Catherine Faucher et al. · Blood · 2003 · 185 citations · Full text